Clinical Trial Update: A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the effectiveness and safety of topiramate for preventing migraines; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Vascular Headaches, Migraine | Phase 3 | Status: COMPLETED